Clearmind Medicine Inc. Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss
Clearmind Medicine Inc. (CMND) reported Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss of $6.26 thousand for the 3-month period ending 2026-01-31, per its 6-K filed 2026-03-12.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss · last filed 2026-03-12
- Clearmind Medicine Inc. gains losses on exchange differences on translation recognised in profit or loss for the quarter ending 2023-01-31 was 42.35K CAD.
- Clearmind Medicine Inc. gains losses on exchange differences on translation recognised in profit or loss for the quarter ending 2022-01-31 was -6.46K CAD.
CAD
| Period end | Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss 3 month |
|---|---|
| 2023-01-31 | 42.35K CAD 6-K · filed 2023-03-17 |
| 2022-01-31 | -6.46K CAD 6-K · filed 2023-03-17 |
USD
| Period end | Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss 3 month | Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss 6 month | Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss 9 month | Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss 12 month |
|---|---|---|---|---|
| 2026-01-31 | $6.26K 6-K · filed 2026-03-12 | $8.78K derived: sum of 2 quarters · filed 2026-03-12 | $11.84K derived: sum of 3 quarters · filed 2026-03-12 | $14.09K derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-10-31 | $2.51K derived: 20-F 12 month − 6-K 9 month · filed 2026-01-20 | $5.58K derived: sum of 2 quarters · filed 2026-01-20 | $7.83K derived: sum of 3 quarters · filed 2026-01-20 | $3.38K 20-F · filed 2026-01-20 |
| 2025-07-31 | $3.07K 6-K · filed 2025-09-11 | $5.31K derived: sum of 2 quarters · filed 2025-09-11 | $864.00 6-K · filed 2025-09-11 | -$2.46K derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-04-30 | $2.25K 6-K · filed 2025-06-12 | -$2.20K 6-K · filed 2025-06-12 | -$5.52K derived: sum of 3 quarters · filed 2026-03-12 | -$10.90K derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-01-31 | -$4.45K 6-K · filed 2026-03-12 | -$7.77K derived: sum of 2 quarters · filed 2026-03-12 | -$13.15K derived: sum of 3 quarters · filed 2026-03-12 | -$11.89K derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-12-31 | $15.74K 6-K · filed 2024-03-19 | |||
| 2024-10-31 | -$3.32K derived: 20-F 12 month − 6-K 9 month · filed 2026-01-20 | -$8.70K derived: sum of 2 quarters · filed 2026-01-20 | -$7.44K derived: sum of 3 quarters · filed 2026-01-20 | -$6.03K 20-F · filed 2026-01-20 |
| 2024-07-31 | -$5.38K 6-K · filed 2025-09-11 | -$4.13K derived: sum of 2 quarters · filed 2025-09-11 | -$2.71K 6-K · filed 2025-09-11 | -$19.13K derived: sum of 4 quarters · filed 2026-01-20 |
| 2024-04-30 | $1.25K 6-K · filed 2025-06-12 | $2.67K 6-K · filed 2025-06-12 | -$13.75K derived: sum of 3 quarters · filed 2026-01-20 | $19.89K derived: sum of 4 quarters · filed 2026-01-20 |
| 2024-01-31 | $1.42K 6-K · filed 2025-03-13 | -$15.01K derived: sum of 2 quarters · filed 2026-01-20 | $18.64K derived: sum of 3 quarters · filed 2026-01-20 | -$42.32K derived: sum of 4 quarters · filed 2026-01-20 |
| 2023-10-31 | -$16.43K derived: 20-F 12 month − 6-K 9 month · filed 2026-01-20 | $17.22K derived: sum of 2 quarters · filed 2026-01-20 | -$43.73K derived: sum of 3 quarters · filed 2026-01-20 | -$78.14K 20-F · filed 2026-01-20 |
| 2023-07-31 | $33.65K 6-K · filed 2024-09-16 | -$27.31K derived: sum of 2 quarters · filed 2024-09-16 | -$61.71K 6-K · filed 2024-09-16 | |
| 2023-04-30 | -$60.95K 6-K · filed 2024-06-13 | -$95.36K 6-K · filed 2024-06-13 | ||
| 2023-01-31 | -$34.40K 6-K · filed 2024-03-19 | |||
| 2022-04-30 | -$9.33K 6-K · filed 2023-06-14 | -$14.07K 6-K · filed 2023-06-14 |